Collaborative ABA Services, LLC has launched the initial rollout of CollabWait, a cloud-based application designed to ...

Horizon Recovery Confirms Ongoing Clinical Operations for Teen Rehabs in Arizona BUCKEYE, AZ, UNITED STATES, January 7, ...

University of Utah alum, Esti, found hope and purpose through Huntsman Mental Health Institute’s Intensive Outpatient Program ...

The FDA has accepted an investigational new drug application for an investigational and proprietary combination therapy to ...

Humans ask what things mean. Animals move on. That difference explains both our brilliance and much of our psychological ...

The 2025 Budget Reconciliation Act, commonly referred to as the One Big Beautiful Bill Act (OBBBA), was signed into law this ...

After testing over 65 therapy services to find the best options, we believe these 11 most affordable online therapy services ...

Department of Oncology, First People’s Hospital of Jingzhou City, Jingzhou, China. With the intensifying global aging population and rising incidence of malignant tumors, the growing number of ...

Oct 3 (Reuters) - Rocket Pharmaceuticals (RCKT.O), opens new tab said on Friday it has withdrawn its application for U.S. approval of its experimental gene therapy for a rare inherited blood disorder.

Having already altered the journey of its rare disease gene therapy to a hoped-for FDA approval, Rocket Pharmaceuticals has now aborted the mission entirely. The biotech initiated a rolling biologics ...

Scientists report the first therapy to slow the deadly brain disease. A one-time gene therapy treatment has shown remarkable success in slowing the progression of Huntington's disease in a preliminary ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...